enGene Therapeutics Inc. - 8-K Filing

enGene Therapeutics updated its corporate presentation on July 17, 2026. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ENGN

Read the full article at SEC EDGAR

More Regulatory news